
    
      Current recommended dosage of Etoposide in treating breast cancer is 50 mg/m2 orally once a
      day for 21 days, repeated every 28 days. With retrospective data review, this study intends
      to adjust Etoposide dose to 60 mg/m2 daily for 10 days, repeated every 21 days as a cycle, to
      investigate the effectiveness and safety of Etoposide monotherapy in the treatment of
      recurrent or metastatic breast cancer in Chinese female patients.
    
  